154 related articles for article (PubMed ID: 22375069)
21. Everolimus and sirolimus in combination with cyclosporine have different effects on renal metabolism in the rat.
Bohra R; Schöning W; Klawitter J; Brunner N; Schmitz V; Shokati T; Lawrence R; Arbelaez MF; Schniedewind B; Christians U; Klawitter J
PLoS One; 2012; 7(10):e48063. PubMed ID: 23118926
[TBL] [Abstract][Full Text] [Related]
22. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus.
Wang ME; Tejpal N; Qu X; Yu J; Okamoto M; Stepkowski SM; Kahan BD
Transplantation; 1998 Apr; 65(7):899-905. PubMed ID: 9565092
[TBL] [Abstract][Full Text] [Related]
23. Pharmacodynamic approach to immunosuppressive therapies using calcineurin inhibitors and mycophenolate mofetil.
Millán O; Brunet M; Campistol JM; Faura A; Rojo I; Vidal E; Jiménez O; Vives J; Oppenheimer F; Martorell J
Clin Chem; 2003 Nov; 49(11):1891-9. PubMed ID: 14578321
[TBL] [Abstract][Full Text] [Related]
24. Cyclosporine-A discourages ethanol intake in C57bl/6j mice: a preliminary study.
Beresford HF; Deitrich R; Beresford TP
J Stud Alcohol; 2005 Sep; 66(5):658-62. PubMed ID: 16331851
[TBL] [Abstract][Full Text] [Related]
25. Drug interaction between cyclosporine and mTOR inhibitors in experimental model of chronic cyclosporine nephrotoxicity and pancreatic islet dysfunction.
Piao SG; Bae SK; Lim SW; Song JH; Chung BH; Choi BS; Yang CW
Transplantation; 2012 Feb; 93(4):383-9. PubMed ID: 22267156
[TBL] [Abstract][Full Text] [Related]
26. Relative tissue distributions of cyclosporine and sirolimus after concomitant peroral administration to the rat: evidence for pharmacokinetic interactions.
Napoli KL; Wang ME; Stepkowski SM; Kahan BD
Ther Drug Monit; 1998 Apr; 20(2):123-33. PubMed ID: 9558125
[TBL] [Abstract][Full Text] [Related]
27. Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection.
Stepkowski SM; Tian L; Napoli KL; Ghobrial R; Wang ME; Chou TC; Kahan BD
Clin Exp Immunol; 1997 Apr; 108(1):63-8. PubMed ID: 9097913
[TBL] [Abstract][Full Text] [Related]
28. Cyclosporine and sirolimus pharmacokinetics and drug-to-drug interactions in kidney transplant recipients.
Felipe CR; Park SI; Pinheiro-Machado PG; Garcia R; Casarini DE; Moreira S; Tedesco-Silva H; Medina-Pestana JO
Fundam Clin Pharmacol; 2009 Oct; 23(5):625-31. PubMed ID: 19656203
[TBL] [Abstract][Full Text] [Related]
29. [Proliferation effects of sirolimus, cyclosporine A and mycophenolate mofetil on human transitional cell carcinoma cells].
Lin J; Wang YH; Zhang YH; Tian Y
Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(6):388-91. PubMed ID: 22490898
[TBL] [Abstract][Full Text] [Related]
30. Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipients.
Barten MJ; Rahmel A; Garbade J; Bold A; Bittner HB; Dhein S; Mohr FW; Gummert JF
Transplant Proc; 2005 Dec; 37(10):4532-4. PubMed ID: 16387162
[TBL] [Abstract][Full Text] [Related]
31. Prospective comparison of the use of sirolimus and cyclosporine in recipients of a kidney from an expanded criteria donor.
Durrbach A; Rostaing L; Tricot L; Ouali N; Wolf P; Pouteil-Noble C; Kessler M; Viron B; Thervet E
Transplantation; 2008 Feb; 85(3):486-90. PubMed ID: 18301342
[TBL] [Abstract][Full Text] [Related]
32. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.
Gonwa TA; Hricik DE; Brinker K; Grinyo JM; Schena FP;
Transplantation; 2002 Dec; 74(11):1560-7. PubMed ID: 12490789
[TBL] [Abstract][Full Text] [Related]
33. Immunosuppressant neurotoxicity in rat brain models: oxidative stress and cellular metabolism.
Klawitter J; Gottschalk S; Hainz C; Leibfritz D; Christians U; Serkova NJ
Chem Res Toxicol; 2010 Mar; 23(3):608-19. PubMed ID: 20148532
[TBL] [Abstract][Full Text] [Related]
34. Comparison of early and late conversion of sirolimus in experimental model of chronic cyclosporine nephropathy.
Kim JY; Ghee JY; Lim SW; Piao SG; Chung BH; Yoon HE; Hwang HS; Choi BS; Kim J; Yang CW
J Korean Med Sci; 2012 Feb; 27(2):160-9. PubMed ID: 22323863
[TBL] [Abstract][Full Text] [Related]
35. Metabolic interaction between cyclosporine and sirolimus.
Bai S; Stepkowski SM; Kahan BD; Brunner LJ
Transplantation; 2004 May; 77(10):1507-12. PubMed ID: 15239612
[TBL] [Abstract][Full Text] [Related]
36. Effects of cyclosporine, tacrolimus and rapamycin on renal calcium transport and vitamin D metabolism.
Lee CT; Ng HY; Lien YH; Lai LW; Wu MS; Lin CR; Chen HC
Am J Nephrol; 2011; 34(1):87-94. PubMed ID: 21691056
[TBL] [Abstract][Full Text] [Related]
37. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
38. Clinically relevant immunosuppressants influence UVB-induced tumor size through effects on inflammation and angiogenesis.
Duncan FJ; Wulff BC; Tober KL; Ferketich AK; Martin J; Thomas-Ahner JM; Allen SD; Kusewitt DF; Oberyszyn TM; Vanbuskirk AM
Am J Transplant; 2007 Dec; 7(12):2693-703. PubMed ID: 17941958
[TBL] [Abstract][Full Text] [Related]
39. TGF-β1 mediates sirolimus and cyclosporine A-induced alteration of barrier function in renal epithelial cells via a noncanonical ERK1/2 signaling pathway.
Martin-Martin N; Slattery C; McMorrow T; Ryan MP
Am J Physiol Renal Physiol; 2011 Dec; 301(6):F1281-92. PubMed ID: 21880834
[TBL] [Abstract][Full Text] [Related]
40. Sirolimus-based immunosuppression with reduce dose cyclosporine or tacrolimus after renal transplantation.
Formica RN; Lorber KM; Friedman AL; Bia MJ; Lakkis F; Smith JD; Lorber MI
Transplant Proc; 2003 May; 35(3 Suppl):95S-98S. PubMed ID: 12742475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
